| Literature DB >> 30943259 |
Andrey A Buglak1,2, Anatoly V Zherdev1, Hong-Tao Lei3, Boris B Dzantiev1.
Abstract
A common task in the immunodetection of structurally close compounds is to analyze the selectivity of immune recognition; it is required to understand the regularities of immune recognition and to elucidate the basic structural elements which provide it. Triazines are compounds of particular interest for such research due to their high variability and the necessity of their monitoring to provide safety for agricultural products and foodstuffs. We evaluated the binding of 20 triazines with polyclonal (pAb) and monoclonal (mAb) antibodies obtained using atrazine as the immunogenic hapten. A total of over 3000 descriptors were used in the quantitative structure-activity relationship (QSAR) analysis of binding activities (pIC50). A comparison of the two enzyme immunoassay systems showed that the system with pAb is much easier to describe using 2D QSAR methodology, while the system with mAb can be described using the 3D QSAR CoMFA. Thus, for the 3D QSAR model of the polyclonal antibodies, the main statistical parameter q2 ('leave-many-out') is equal to 0.498, and for monoclonal antibodies, q2 is equal to 0.566. Obviously, in the case of pAb, we deal with several targets, while in the case of mAb the target is one, and therefore it is easier to describe it using specific fields of molecular interactions distributed in space.Entities:
Mesh:
Substances:
Year: 2019 PMID: 30943259 PMCID: PMC6447172 DOI: 10.1371/journal.pone.0214879
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Molecular structure of arylamino-s-triazines (based on Dankwardt et al., 1996).
Cross-reactivity (CR) and concentration of 50% inhibition for the interaction of triazines with polyclonal (S2) and monoclonal antibodies (K4E7), according to Dankwardt et al., 1996.
| № | Compound | CR, % | IC50, nmol l-1 | ||
|---|---|---|---|---|---|
| S2 | K4E7 | S2 | K4E7 | ||
| 1 | 2-chloro-4-isopropylamino-6-ethylamino-1,3,5-triazine (atrazine) | 100 | 100 | 0.93 | 0.37 |
| 2 | 2-chloro-4-isopropylamino-6-amino-1,3,5-triazine (deethylatrazine) | 15 | 18 | 6.0 | 2.1 |
| 3 | 2-chloro-4-ethylamino-6-amino-1,3,5-triazine (deisopropylatrazine) | 0.4 | 1.8 | 232 | 20.6 |
| 4 | 2-hydroxy-4-isopropylamino-6-ethylamino-1,3,5-triazine (hydroxyatrazine) | 6 | 0.1 | 15.3 | 371 |
| 5 | 2-chloro-4-anilino-6-isopropylamino-1,3,5-triazine | 106 | 140 | 0.88 | 0.27 |
| 6 | 2-chloro-4-(3’,4’-dimethoxyanilino)-6-isopropylamino-1,3,5-triazine | 126 | 140 | 0.74 | 0.27 |
| 7 | 2-chloro-4-(3’,4’-dimethoxybenzylamino)-6-isopropylamino-1,3,5-triazine | 109 | 148 | 0.84 | 0.25 |
| 8 | 2-chloro-4-(3’-hydroxy-4’-methoxyanilino)-6-isopropylamino-1,3,5-triazine | 74 | 79 | 1.25 | 0.47 |
| 9 | 2-chloro-4-(2’-carboxy-4’,5’-dimethoxyanilino)-6-isopropylamino-1,3,5-triazine | 9 | <0.1 | 10.3 | >500 |
| 10 | 2-chloro-4-(2’-nitrilanilino)-6-isopropylamino-1,3,5-triazine | 134 | 70 | 0.70 | 0.52 |
| 11 | 2-chloro-4-(3’-nitrilanilino)-6-isopropylamino-1,3,5-triazine | 134 | 108 | 0.70 | 0.34 |
| 12 | 2-chloro-4-(4’-nitrilanilino)-6-isopropylamino-1,3,5-triazine | 101 | 107 | 0.93 | 0.35 |
| 13 | 2-chloro-4-(2’-triflourmethylanilino)-6-isopropylamino-1,3,5-triazine | 91 | 81 | 1.02 | 0.46 |
| 14 | 2-chloro-4-(3’-triflourmethylanilino)-6-isopropylamino-1,3,5-triazine | 133 | 75 | 0.70 | 0.46 |
| 15 | 2-chloro-4-(4’-triflourmethylanilino)-6-isopropylamino-1,3,5-triazine | 92 | 129 | 1.02 | 0.49 |
| 16 | 2-chloro-4-(3’,4’-dimethoxyanilino)-6-ethylamino-1,3,5-triazine | 5 | 10 | 18.6 | 3.68 |
| 17 | 2-hydroxy-4-anilino-6-isopropylamino-1,3,5-triazine | 0.4 | 0.2 | 232 | 186 |
| 18 | 2-hydroxy-4-(3’,4’-dimethoxyanilino)-6-isopropylamino-1,3,5-triazine | 0.4 | 0.2 | 232 | 186 |
| 19 | 2-chloro-4-anilino-6-amino-1,3,5-triazine | 0.1 | <0.1 | 500 | >500 |
| 20 | 2-chloro-4-(3’,4’-dimethoxyanilino)-6-amino-1,3,5-triazine | <0.1 | <0.1 | >500 | >500 |
Fig 2The most energetically favorable conformations of compounds 5, 11 and 12 according to the calculation by HF/6-31G(d) method.
Fig 3Triazine geometries optimized with the AM1 method (hydrogen atoms are represented only in -OH groups).
Statistical parameters of the models for the S2 system.
| № | Statistical parameter | Model 1 | Model 2 | Model 3 | Model 4 | Model 5 |
|---|---|---|---|---|---|---|
| 1 | 0.941 | 0.890 | 0.937 | 0.937 | ||
| 2 | 0.926 | 0.873 | 0.921 | 0.921 | ||
| 3 | 0.893 | 0.843 | 0.898 | 0.873 | ||
| 4 | 0.913 | 0.924 | 0.870 | 0.920 | ||
| 5 | 0.567 | 0.904 | 0.746 | 0.549 | ||
| 6 | 0.295 | 0.387 | 0.305 | 0.306 | ||
| 7 | 0.383 | 0.411 | 0.412 | 0.355 |
Fig 4Comparison of experimental pIC50 values for triazine interactions with polyclonal antibodies (S2) and predicted activity based on Model 5; compounds 4, 6, 14 and 19 were used as a test set.
Statistical parameters of 2D QSAR models for the K4E7 system.
| № | Statistical parameters | Model 6 | Model 7 | Model 8 | Model 9 | Model 10 |
|---|---|---|---|---|---|---|
| 1 | 0.921 | 0.915 | 0.917 | 0.925 | ||
| 2 | 0.902 | 0.894 | 0.896 | 0.906 | ||
| 3 | 0.819 | 0.778 | 0.862 | 0.832 | ||
| 4 | 0.767 | 0.788 | 0.898 | 0.704 | ||
| 5 | 0.947 | 1.110 | 1.065 | 0.913 | ||
| 6 | 0.431 | 0.449 | 0.444 | 0.422 | ||
| 7 | 0.822 | 0.890 | 0.869 | 0.787 |
Fig 5Comparison of experimental pIC50 values for triazine interactions with monoclonal antibodies (K4E7) and predicted activity based on Model 10; compounds 6, 10, 16 and 20 were used as a test set.
Experimental and predicted values of the triazine cross-reactivity logarithm (pIC50) in the S2 system.
| № | Experiment | Prediction |
|---|---|---|
| 1 | 9.032 | 9.056 |
| 2 | 8.222 | 8.405 |
| 3 | 6.635 | 6.846 |
| 4 | 7.815 | 7.297 |
| 5 | 9.056 | 8.641 |
| 6 | 9.131 | 8.763 |
| 7 | 9.076 | 9.393 |
| 8 | 8.903 | 8.713 |
| 9 | 7.987 | 7.878 |
| 10 | 9.155 | 9.492 |
| 11 | 9.155 | 9.276 |
| 12 | 9.032 | 8.811 |
| 13 | 8.991 | 9.147 |
| 14 | 9.155 | 9.108 |
| 15 | 8.991 | 9.016 |
| 16 | 7.731 | 7.406 |
| 17 | 6.635 | 7.039 |
| 18 | 6.635 | 6.950 |
| 19 | 6.301 | 6.529 |
| 20 | 6.301 | 6.170 |
Statistical parameters of the CoMFA model for the S2 system.
SDEP: mean-square error of prediction. LOO: leave-one-out.
| № | R2 | SDEC | F-test | q2(LOO) | SDEP(LOO) | q2(LMO) | SDEP(LMO) |
|---|---|---|---|---|---|---|---|
| 3 | 0.938 | 0.269 | 80.39 | 0.680 | 0.610 | 0.498 | 0.754 |
Fig 6Experimental vs. predicted values of triazine cross-reactivity in the S2 system according to the CoMFA method (3D QSAR).
Fig 7The molecular interaction field (MIF) contour maps for system S2 and compound 7: (a) favorable steric interactions; (b) unfavorable steric interactions; (c) sites favorable for positively charged groups; (d) sites favorable for negatively charged groups.
Experimental and predicted values of triazine cross-reactivity in the K4E7 system.
| № | Experiment | Prediction |
|---|---|---|
| 1 | 9.432 | 9.120 |
| 2 | 8.678 | 8.786 |
| 3 | 7.686 | 7.746 |
| 4 | 6.431 | 6.429 |
| 5 | 9.569 | 9.031 |
| 6 | 9.569 | 9.361 |
| 7 | 9.602 | 9.397 |
| 8 | 9.328 | 8.894 |
| 9 | 6.301 | 6.442 |
| 10 | 9.284 | 9.455 |
| 11 | 9.469 | 9.462 |
| 12 | 9.456 | 9.871 |
| 13 | 9.337 | 9.212 |
| 14 | 9.337 | 9.776 |
| 15 | 9.310 | 9.527 |
| 16 | 8.434 | 8.497 |
| 17 | 6.731 | 6.721 |
| 18 | 6.731 | 6.362 |
| 19 | 6.301 | 6.931 |
| 20 | 6.301 | 6.266 |
Fig 8K4E7 system’s experimental and predicted pIC50 triazine values based on the CoMFA method (3D QSAR).
Statistical parameters of the 3D QSAR model for the K4E7 system.
| № | R2 | SDEC | F-test | q2(LOO) | SDEP(LOO) | q2(LMO) | SDEP(LMO) |
|---|---|---|---|---|---|---|---|
| 3 | 0.952 | 0.291 | 105.0 | 0.637 | 0.796 | 0.566 | 0.861 |
Fig 9MIF contour maps for the K4E7 system: (a) favorable steric interactions and (b) unfavorable steric interactions for compound 11; (c) sites favorable for positively charged groups; (d) sites favorable for negatively charged groups for compound 12.